Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

The deal is a bet on the growing market for psychiatric and neurological drugs.

Lauren Hirsch
Author: Lauren Hirsch

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.